🚀 VC round data is live in beta, check it out!
Brain+ Valuation Multiples
Discover revenue and EBITDA valuation multiples for Brain+ and similar public comparables like Monsenso, Telemedycyna Polska, Aino Health, Medondo Holding and more.
Brain+ Overview
About Brain+
Brain+ AS is a digital therapeutics company. It is focused on developing and commercializing solutions for dementia care and with a primary focus on Cognitive Stimulation Therapy (CST). The company has developed a set of Digital Medicine technologies. Its product pipeline includes CST Therapist Companion, and CST Home Companion; CST Home Care; CST for Mild Cognitive Impairment (MCI). The company is developing Ayla, a scalable dementia care platform that provides software-based therapy and care solutions designed to support individuals with dementia.
Founded
2012
HQ
Employees
12
Website
Sectors
Financials (FY)
Market Cap
$461K
Brain+ Stock Performance
Brain+ has current market cap of $461K.
Market Cap Evolution
Brain+'s stock price is $0.00.
| Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|
| $461K | 0.0% | XXX | XXX | XXX | — |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBrain+ Valuation Multiples
Brain+ Financial Valuation Multiples
As of April 19, 2026, Brain+ has market cap of $461K.
Equity research analysts estimate Brain+'s 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $461K | XXX | $461K | XXX | XXX | XXX |
| EV (current) | ($219K) | XXX | ($219K) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Brain+ Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Brain+ Public Comps
See public comps and valuation multiples for other Digital Therapeutics and Health Data & Analytics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Brain+ | XXX | XXX | XXX | XXX | XXX | XXX |
| Monsenso | XXX | XXX | XXX | XXX | XXX | XXX |
| Telemedycyna Polska | XXX | XXX | XXX | XXX | XXX | XXX |
| Aino Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Medondo Holding | XXX | XXX | XXX | XXX | XXX | XXX |
| Ludwig Enterprises | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Brain+ M&A Activity
Brain+ acquired XXX companies to date.
Last acquisition by Brain+ was on XXXXXXXX, XXXXX. Brain+ acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Brain+
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialBrain+ Investment Activity
Brain+ invested in XXX companies to date.
Brain+ made its latest investment on XXXXXXXX, XXXXX. Brain+ invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Brain+
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Brain+
| When was Brain+ founded? | Brain+ was founded in 2012. |
| Where is Brain+ headquartered? | Brain+ is headquartered in Denmark. |
| How many employees does Brain+ have? | As of today, Brain+ has over 12 employees. |
| Is Brain+ publicly listed? | Yes, Brain+ is a public company listed on Nasdaq Copenhagen. |
| What is the stock symbol of Brain+? | Brain+ trades under BRAINP ticker. |
| When did Brain+ go public? | Brain+ went public in 2021. |
| Who are competitors of Brain+? | Brain+ main competitors are Monsenso, Telemedycyna Polska, Aino Health, Medondo Holding. |
| What is the current market cap of Brain+? | Brain+'s current market cap is $461K. |
| Is Brain+ profitable? | No, Brain+ is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.